文献速递神经肿瘤功能神经外科

清醒开颅联合经皮层运动诱发电位监测预测中央前回胶质瘤术后运动功能

Awake craniotomy with transcortical motor evoked potential monitoring for resection of gliomas in the precentral gyrus: utility for predicting motor function.
PubMed 文献 · J Neurosurg · 2019-03-15

本研究纳入30例清醒开颅切除中央前回胶质瘤患者,术中联合监测自主运动(IVM)与经皮层运动诱发电位(MEP)。术后6个月运动功能与IVM、MEP变化(下降≤或>50%)、切除程度及术后MRI缺血灶显著相关;联合判断有助于预测术后运动功能,最大程度切除可获得可接受的并发症率。

要点

  • 清醒开颅联合IVM与经皮层MEP监测可用于预测中央前回胶质瘤术后运动功能。
  • IVM无变化者术后6个月运动功能稳定;IVM下降且MEP下降>50%者运动功能下降比例更高。
  • 中央前回胶质瘤不应被视为不可切除,最大程度切除可获得可接受的并发症率。

核心结论

  • 联合判断清醒开颅术中IVM监测与经皮层MEP监测有助于预测中央前回胶质瘤切除术后运动功能。
  • 最大程度切除可获得可接受的并发症率,这些肿瘤不应被视为不可切除。

研究设计与样本

  • 当前研究纳入2000年4月至2018年1月期间30例接受清醒开颅中央前回胶质瘤切除的患者。
  • 所有肿瘤均在清醒开颅术中IVM监测和经皮层MEP监测下切除。
  • 术后运动功能分为稳定或下降,下降程度分为轻度、中度或重度;中度和重度缺陷定义为妨碍日常生活。

主要发现

  • 30例中28例经皮层MEP获得可用波形,平均切除程度(EOR)为93%。
  • 术后6个月运动功能较术前稳定20例,轻度下降7例,中度下降2例,重度下降1例。
  • 术后6个月运动功能与IVM(p = 0.0096)、经皮层MEP变化(下降≤或>50%)(p = 0.0163)、EOR及术后MRI缺血灶显著相关。
  • IVM无变化的6例患者术后6个月运动功能稳定。
  • IVM下降且MEP下降≤50%的11例中仅2例术后6个月运动功能下降(18%;2/11),而IVM下降且MEP下降>50%的11例中8例运动功能下降(73%;8/11),包括2例中度、1例重度缺陷。

临床怎么用

  • 清醒开颅术中联合IVM与经皮层MEP监测可用于预测中央前回胶质瘤术后运动功能。
  • 中央前回胶质瘤不应被视为不可切除,最大程度切除可获得可接受的并发症率。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Resection of gliomas in the precentral gyrus carries a risk of severe motor dysfunction. To prevent permanent, severe postoperative motor dysfunction, reliable intraoperative predictors of postoperative function are required. Since 2005, the authors have removed gliomas in the precentral gyrus with combined functional mapping and estimation of intraoperative voluntary movement (IVM) during awake craniotomy and transcortical motor evoked potentials (MEPs). The purpose of the current study was to evaluate whether intraoperative findings of combined monitoring of IVM during awake craniotomy and transcortical MEP monitoring were useful for predicting postoperative motor function of patients with gliomas in the precentral gyrus. METHODS: The current study included 30 patients who underwent resection of precentral gyrus gliomas during awake craniotomy from April 2000 to January 2018. All tumors were removed with monitoring of IVM during awake craniotomy and transcortical MEPs. Postoperative motor function was classified as stable or declined, with the extent of decline categorized as mild, moderate, or severe. We defined moderate and severe deficits were those that hindered daily life. RESULTS: In 28 of 30 cases, available waveforms were obtained with transcortical MEPs. The mean extent of resection (EOR) was 93%. Relative to preoperative status, motor function 6 months after surgery was considered stable in 20 patients and was considered to show mild decline in 7, moderate decline in 2, and severe decline in 1. Motor function 6 months after surgery was significantly correlated with IVM (p = 0.0096), changes in transcortical MEPs (decline ≤ or > 50%) (p = 0.0163), EOR, and ischemic lesions on postoperative MRI. Six patients with no change in IVM showed stable motor function 6 months after surgery. Only 2 patients with a decline in IVM and a decline in MEPs ≤ 50% had a decline in motor function 6 months after surgery (18%; 2/11 patients), whereas 11 patients with a decline in IVM and a decline in MEPs > 50% had such a decline in motor function (73%; 8/11 patients) including 2 patients with moderate and 1 with severe deficits. Three patients with moderate or severe motor deficits showed the lowest MEP values (< 100 µV). CONCLUSIONS: Combined judgment from monitoring of IVM during awake craniotomy and transcortical MEPs is useful for predicting postoperative motor function during removal of gliomas in the precentral gyrus. Maximum resection was achieved with an acceptable morbidity rate. Thus, these tumors should not be considered unresectable.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Saito T, Muragaki Y, Tamura M, et al. Awake craniotomy with transcortical motor evoked potential monitoring for resection of gliomas in the precentral gyrus: utility for predicting motor function. J Neurosurg. 2019. PMID: 30875689. doi:10.3171/2018.11.JNS182609

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。